Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US Preventive Services Task Force

R Chou, A Cantor, T Dana, J Wagner, AY Ahmed, R Fu… - Jama, 2022 - jamanetwork.com
Importance A 2016 review for the US Preventive Services Task Force (USPSTF) found use
of statins for primary prevention of cardiovascular disease (CVD) was associated with …

The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)

S Umemura, H Arima, S Arima, K Asayama… - Hypertension …, 2019 - nature.com
The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of …

SM Grundy, NJ Stone, AL Bailey, C Beam, KK Birtcher… - Circulation, 2019 - Am Heart Assoc
The American Heart Association requests that this document be cited as follows: Grundy SM,
Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella …

Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta …

T Cai, L Abel, O Langford, G Monaghan, JK Aronson… - Bmj, 2021 - bmj.com
Objective To assess the associations between statins and adverse events in primary
prevention of cardiovascular disease and to examine how the associations vary by type and …

Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study

C Razo, CA Welgan, CO Johnson, SA McLaughlin… - Nature medicine, 2022 - nature.com
High systolic blood pressure (SBP) is a major risk factor for ischemic heart disease (IHD), the
leading cause of death worldwide. Using data from published observational studies and …

Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: meta-analysis of 119 clinical trials involving 100 667 patients

P Willeit, L Tschiderer, E Allara, K Reuber… - Circulation, 2020 - Am Heart Assoc
Background: To quantify the association between effects of interventions on carotid intima-
media thickness (cIMT) progression and their effects on cardiovascular disease (CVD) risk …

Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US Preventive Services Task Force

R Chou, T Dana, I Blazina, M Daeges, TL Jeanne - Jama, 2016 - jamanetwork.com
Importance Cardiovascular disease (CVD), the leading cause of mortality and morbidity in
the United States, may be potentially preventable with statin therapy. Objective To …

Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis

M Brunström, B Carlberg - JAMA internal medicine, 2018 - jamanetwork.com
Importance High blood pressure (BP) is the most important risk factor for death and
cardiovascular disease (CVD) worldwide. The optimal cutoff for treatment of high BP is …

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

RT Gansevoort, R Correa-Rotter, BR Hemmelgarn… - The Lancet, 2013 - thelancet.com
Since the first description of the association between chronic kidney disease and heart
disease, many epidemiological studies have confirmed and extended this finding. As …

Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data

Blood Pressure Lowering Treatment Trialists' … - The Lancet, 2014 - Elsevier
Background We aimed to investigate whether the benefits of blood pressure-lowering drugs
are proportional to baseline cardiovascular risk, to establish whether absolute risk could be …